Oncol Lett 21: [Related article:] 283, 2021; DOI:
10.3892/ol.2021.12544
Following the publication of this paper, a concerned
reader drew to the Editor's attention that there appeared to be
quite an extensive overlap of data (albeit with a different
microRNA being reported on) with the following article, which
contained an entirely different set of authors based at different
research institutions: Li S, Zhang S, Yang W, Li F and Long H:
Diagnostic value of exosomal miR-148a-3p in the serum of patients
with differentiated thyroid cancer. Clin Lab: 67, 2021. The
Editorial Office conducted an independent investigation of this
matter, and were able to substantiate the reader's claims;
moreover, a paper submitted to and accepted in the journal
Kaohsiung J Med Sci over a similar time period, which did feature
some of the same authors as the abovementioned Oncol Lett paper,
likewise contained several of the same data.
Owing to the fact that a large number of data in
this paper had also been published in two other articles that were
accepted at approximately the same time, the Editor of Oncology
Letters has decided that this paper should be retracted from
the journal. he authors were asked for an explanation to account
for these concerns, but the Editorial Office did not receive a
reply. The Editor apologizes to the readership for any
inconvenience caused.
